Jump to main content
Jump to site search

Issue 30, 2017
Previous Article Next Article

Ru(II)-(PTA) and -mPTA complexes with N2-donor ligands bipyridyl and phenanthroline and their antiproliferative activities on human multiple myeloma cell lines

Author affiliations

Abstract

A series of novel ruthenium(II) 2,2′-bipyridyl (bpy) and 1,10-phenanthroline (phen) derivatives containing PTA (1,3,5-triaza-7-phosphaadamantane) or mPTA (N-methyl-1,3,5-triaza-7-phosphaadamantane cation) have been synthesized and fully characterized. Three types of complexes have been obtained, neutral [Ru(N–N)(PTA)2Cl2] (1, N–N = bpy and 4, N–N = phen), monocationic [Ru(N–N)(PTA)3Cl][Cl] (2, N–N = bpy and 5, N–N = phen) and dicationic [Ru(N–N)(mPTA)Cl2][BF4]2 (3, N–N = bpy and 6, N–N = phen). The solid-state structures of four complexes have been determined by single-crystal X-ray diffraction. The cytotoxicity of the complexes has been evaluated in vitro against U266 and RPMI human multiple myeloma cells.

Graphical abstract: Ru(ii)-(PTA) and -mPTA complexes with N2-donor ligands bipyridyl and phenanthroline and their antiproliferative activities on human multiple myeloma cell lines

Back to tab navigation

Supplementary files

Publication details

The article was received on 05 Jun 2017, accepted on 04 Jul 2017 and first published on 07 Jul 2017


Article type: Paper
DOI: 10.1039/C7DT02051A
Citation: Dalton Trans., 2017,46, 10073-10081
  •   Request permissions

    Ru(II)-(PTA) and -mPTA complexes with N2-donor ligands bipyridyl and phenanthroline and their antiproliferative activities on human multiple myeloma cell lines

    A. Wołoszyn, C. Pettinari, R. Pettinari, G. V. Badillo Patzmay, A. Kwiecień, G. Lupidi, M. Nabissi, G. Santoni and P. Smoleński, Dalton Trans., 2017, 46, 10073
    DOI: 10.1039/C7DT02051A

Search articles by author

Spotlight

Advertisements